ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
出版年份 2018 全文链接
标题
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
作者
关键词
-
出版物
Cell Death & Disease
Volume 9, Issue 9, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-29
DOI
10.1038/s41419-018-0926-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Context-dependent effects of cellular senescence in cancer development
- (2016) Pacome Lecot et al. BRITISH JOURNAL OF CANCER
- Keeping your senescent cells under control
- (2016) Lars Zender et al. Aging-US
- Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade
- (2015) Dong-Xian Guan et al. HEPATOLOGY
- Anti-inflammatory effect of Marchantin M contributes to sensitization of prostate cancer cells to docetaxel
- (2014) Leilei Niu et al. CANCER LETTERS
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- The Molecular Balancing Act of p16 INK4a in Cancer and Aging
- (2013) Kyle M. LaPak et al. MOLECULAR CANCER RESEARCH
- Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1
- (2013) Anni Laine et al. Cancer Discovery
- Sorafenib Inhibits Hypoxia-Inducible Factor-1 Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma
- (2012) L.-p. Liu et al. CLINICAL CANCER RESEARCH
- Cellular senescence and cancer chemotherapy resistance
- (2012) Ryan R. Gordon et al. DRUG RESISTANCE UPDATES
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
- (2011) B. G. Bitler et al. CANCER RESEARCH
- Cellular senescence and tumor suppressor gene p16
- (2011) Hani Rayess et al. INTERNATIONAL JOURNAL OF CANCER
- Four faces of cellular senescence
- (2011) Francis Rodier et al. JOURNAL OF CELL BIOLOGY
- Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
- (2011) Uzma Asghar et al. JOURNAL OF HEPATOLOGY
- Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer
- (2011) Takeo Kosaka et al. JOURNAL OF UROLOGY
- Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
- (2011) Lars-Gunnar Larsson SEMINARS IN CANCER BIOLOGY
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
- (2010) Jean-Philippe Coppé et al. Annual Review of Pathology-Mechanisms of Disease
- Overexpressed Id-1 is associated with patient prognosis and HBx expression in hepatitis B virus-related hepatocellular carcinoma
- (2010) Rui Ding et al. CANCER BIOLOGY & THERAPY
- ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
- (2010) H. Geng et al. CANCER RESEARCH
- Survivin and escaping in therapy-induced cellular senescence
- (2010) Qin Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
- (2010) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now